The DOI matches its Crossref record; 114 of the 114 references it cites were found in a registry or an index.
The p53 network: cellular and systemic DNA damage responses in cancer and aging
Abstract
The tumor protein TP53 gene, encoding the cellular tumor antigen p53, is the single most frequently mutated gene in human cancers. p53 plays a central role in responding to DNA damage and determines the outcome of the DNA damage checkpoint response by regulating cell cycle arrest and apoptosis. As a consequence of this function, dysfunctional p53 results in cells that, despite a damaged genome, continue to proliferate thus fueling malignant transformation. New insights have recently been gained into the complexity of the p53 regulation of the DNA damage response (DDR) and how it impacts a wide variety of cellular processes. In addition to cell-autonomous signaling mechanisms, non-cell-autonomous regulatory inputs influence p53 activity, which in turn can have systemic consequences on the organism. New inroads have also been made toward therapeutic targeting of p53 that for a long time has been anticipated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Stabilized p53 forms tetramers in the nucleus, binds to target DNA and regulates gene transcription, leading to alterations in downstream signaling pathways.33–37”
From Targeting p53 pathways: mechanisms, structures, and advances in therapy (2023) · cites this paper as [34]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
Instability and decay of the primary structure of DNA
Lindahl, T. (1993) · Nature · doi:10.1038/362709a0 · Cited by 5,679
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
The DNA damage response: putting checkpoints in perspective
Zhou, B.-B. S., & Elledge, S. J. (2000) · Nature · doi:10.1038/35044005 · Cited by 3,213
Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic Mutations
Cho, Y., Gorina, S., Jeffrey, P. D., & Pavletich, N. P. (1994) · Science · doi:10.1126/science.8023157 · Cited by 2,551
Linzer, D. I. H., & Levine, A. J. (1979) · Cell · doi:10.1016/0092-8674(79)90293-9 · Cited by 1,813
The p66shc adaptor protein controls oxidative stress response and life span in mammals
Migliaccio, E., Giorgio, M., Mele, S., Pelicci, G., Reboldi, P., Pandolfi, P. P., Lanfrancone, L., & Pelicci, P. G. (1999) · Nature · doi:10.1038/46311 · Cited by 1,712
The DNA Damage Response: Ten Years After
Harper, J. W., & Elledge, S. J. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.11.015 · Cited by 1,705
Genomic Instability and Aging-like Phenotype in the Absence of Mammalian SIRT6
Mostoslavsky, R., Chua, K. F., Lombard, D. B., Pang, W. W., Fischer, M. R., Gellon, L., Liu, P., Mostoslavsky, G., Franco, S., Murphy, M. M., et al. (2006) · Cell · doi:10.1016/j.cell.2005.11.044 · Cited by 1,637
Rate of depurination of native deoxyribonucleic acid
Lindahl, T., & Nyberg, B. (1972) · Biochemistry · doi:10.1021/bi00769a018 · Cited by 1,556
p53 mutant mice that display early ageing-associated phenotypes
Tyner, S. D., Venkatachalam, S., Choi, J., Jones, S., Ghebranious, N., Igelmann, H., Lu, X., Soron, G., Cooper, B., Brayton, C., et al. (2002) · Nature · doi:10.1038/415045a · Cited by 1,459
Endogenous DNA damage as a source of genomic instability in cancer
Tubbs, A., & Nussenzweig, A. (2017) · Cell · doi:10.1016/j.cell.2017.01.002 · Cited by 1,452
Telomere dysfunction induces metabolic and mitochondrial compromise
Sahin, E., Colla, S., Liesa, M., Moslehi, J., Müller, F. L., Guo, M., Cooper, M., Kotton, D., Fabian, A. J., Walkey, C., et al. (2011) · Nature · doi:10.1038/nature09787 · Cited by 1,319
Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome
Olive, K. P., Tuveson, D. A., Ruhe, Z. C., Yin, B., Willis, N. A., Bronson, R. T., Crowley, D., & Jacks, T. (2004) · Cell · doi:10.1016/j.cell.2004.11.004 · Cited by 1,308
Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage
Falck, J., Coates, J., & Jackson, S. P. (2005) · Nature · doi:10.1038/nature03442 · Cited by 1,258
Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome
Lang, G. A., Iwakuma, T., Suh, Y.-A., Liu, G., Rao, V. A., Parant, J. M., Valentin-Vega, Y. A., Terzian, T., Caldwell, L. C., Strong, L. C., et al. (2004) · Cell · doi:10.1016/j.cell.2004.11.006 · Cited by 1,069
Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound
Bykov, V. J. N., Issaeva, N., Shilov, A., Hultcrantz, M., Pugacheva, E., Chumakov, P., Bergman, J., Wiman, K. G., & Selivanova, G. (2002) · Nature Medicine · doi:10.1038/nm0302-282 · Cited by 1,067
Jonkers, J., Meuwissen, R., van der Gulden, H., Peterse, H., van der Valk, M., & Berns, A. (2001) · Nature Genetics · doi:10.1038/ng747 · Cited by 1,053
Shieh, S.-Y., Ahn, J., Tamai, K., Taya, Y., & Prives, C. (2000) · Genes & Development · doi:10.1101/gad.14.3.289 · Cited by 972
The central role of DNA damage in the ageing process
Schumacher, B., Pothof, J., Vijg, J., & Hoeijmakers, J. H. J. (2021) · Nature · doi:10.1038/s41586-021-03307-7 · Cited by 907
Self-citationp53 in the DNA–Damage–Repair Process
Williams, A. B., & Schumacher, B. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026070 · Cited by 835
Self-citationNon-Cell-Autonomous Tumor Suppression by p53
Lujambio, A., Akkari, L., Simon, J., Grace, D., Tschaharganeh, D. F., Bolden, J. E., Zhao, Z., Thapar, V., Joyce, J. A., Krizhanovsky, V., et al. (2013) · Cell · doi:10.1016/j.cell.2013.03.020 · Cited by 766
DeLeo, A. B., Jay, G., Appella, E., Dubois, G. C., Law, L. W., & Old, L. J. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.5.2420 · Cited by 721
Why are there hotspot mutations in the TP53 gene in human cancers?
Baugh, E. H., Ke, H., Levine, A. J., Bonneau, R. A., & Chan, C. S. (2018) · Cell Death & Differentiation · doi:10.1038/cdd.2017.180 · Cited by 607
Modeling the Therapeutic Efficacy of p53 Restoration in Tumors
Martins, C. P., Brown-Swigart, L., & Evan, G. I. (2006) · Cell · doi:10.1016/j.cell.2006.12.007 · Cited by 600
Modulation of mammalian life span by the short isoform of p53
Maier, B., Gluba, W., Bernier, B., Turner, T., Mohammad, K., Guise, T., Sutherland, A., Thorner, M., & Scrable, H. (2004) · Genes & Development · doi:10.1101/gad.1162404 · Cited by 586
Transcriptional Regulation by P53
Beckerman, R., & Prives, C. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000935 · Cited by 569
'Super p53' mice exhibit enhanced DNA damage response, are tumor resistant and age normally
García‐Cao, I., García‐Cao, M., Martín‐Caballero, J., Criado, L. M., Klatt, P., Flores, J. M., Weill, J., Blasco, M. A., & Serrano, M. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf595 · Cited by 529
Loss of p53 triggers WNT-dependent systemic inflammation to drive breast cancer metastasis
Wellenstein, M. D., Coffelt, S. B., Duits, D. E. M., van Miltenburg, M. H., Slagter, M., de Rink, I., Henneman, L., Kas, S. M., Prekovic, S., Hau, C.-S., et al. (2019) · Nature · doi:10.1038/s41586-019-1450-6 · Cited by 500
Mutant p53 cancers reprogram macrophages to tumor supporting macrophages via exosomal miR-1246
Cooks, T., Pateras, I. S., Jenkins, L. M., Patel, K. M., Robles, A. I., Morris, J., Forshew, T., Appella, E., Gorgoulis, V. G., & Harris, C. C. (2018) · Nature Communications · doi:10.1038/s41467-018-03224-w · Cited by 482
Drosophila p53 Binds a Damage Response Element at the reaper Locus
Brodsky, M. H., Nordstrom, W., Tsang, G., Kwan, E., Rubin, G. M., & Abrams, J. M. (2000) · Cell · doi:10.1016/s0092-8674(00)80627-3 · Cited by 473
Caenorhabditis elegans p53: Role in Apoptosis, Meiosis, and Stress Resistance
Derry, W. B., Putzke, A. P., & Rothman, J. H. (2001) · Science · doi:10.1126/science.1065486 · Cited by 464
Drosophila p53 Is a Structural and Functional Homolog of the Tumor Suppressor p53
Ollmann, M., Young, L. M., Di Como, C. J., Karim, F., Belvin, M., Robertson, S., Whittaker, K., Demsky, M., Fisher, W. W., Buchman, A., et al. (2000) · Cell · doi:10.1016/s0092-8674(00)80626-1 · Cited by 412
MDM2 inhibition: an important step forward in cancer therapy
Konopleva, M., Martinelli, G., Daver, N., Papayannidis, C., Wei, A., Higgins, B., Ott, M., Mascarenhas, J., & Andreeff, M. (2020) · Leukemia · doi:10.1038/s41375-020-0949-z · Cited by 376
Targeting a neoantigen derived from a common TP53 mutation
Hsiue, E. H.-C., Wright, K. M., Douglass, J., Hwang, M. S., Mog, B. J., Pearlman, A. H., Paul, S., DiNapoli, S. R., Konig, M. F., Wang, Q., et al. (2021) · Science · doi:10.1126/science.abc8697 · Cited by 367
The C. elegans homolog of the p53 tumor suppressor is required for DNA damage-induced apoptosis
Schumacher, B., Hofmann, K., Boulton, S., & Gartner, A. (2001) · Current Biology · doi:10.1016/s0960-9822(01)00534-6 · Cited by 360
Self-citationZhang, R., Qi, F., Zhao, F., Li, G., Shao, S., Zhang, X., Yuan, L., & Feng, Y. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1435-2 · Cited by 343
Sulak, M., Fong, L., Mika, K., Chigurupati, S., Yon, L., Mongan, N. P., Emes, R. D., & Lynch, V. J. (2016) · eLife · doi:10.7554/elife.11994 · Cited by 339
Saito, S., Goodarzi, A. A., Higashimoto, Y., Noda, Y., Lees-Miller, S. P., Appella, E., & Anderson, C. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200093200 · Cited by 303
Cao, L., Li, W., Kim, S., Brodie, S. G., & Deng, C.-X. (2003) · Genes & Development · doi:10.1101/gad.1050003 · Cited by 293
Gok Yavuz, B., Gunaydin, G., Gedik, M. E., Kosemehmetoglu, K., Karakoc, D., Ozgur, F., & Guc, D. (2019) · Scientific Reports · doi:10.1038/s41598-019-39553-z · Cited by 292
Hofmann, E. R., Milstein, S., Boulton, S. J., Ye, M., Hofmann, J. J., Stergiou, L., Gartner, A., Vidal, M., & Hengartner, M. O. (2002) · Current Biology · doi:10.1016/s0960-9822(02)01262-9 · Cited by 284
APR-246 reactivates mutant p53 by targeting cysteines 124 and 277
Zhang, Q., Bykov, V. J. N., Wiman, K. G., & Zawacka-Pankau, J. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-0463-7 · Cited by 261
Inherited TP53 Mutations and the Li–Fraumeni Syndrome
Guha, T., & Malkin, D. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026187 · Cited by 253
Cooperative Binding of Tetrameric p53 to DNA
Weinberg, R. L., Veprintsev, D. B., & Fersht, A. R. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.06.071 · Cited by 250
The impact of altered p53 dosage on hematopoietic stem cell dynamics during aging
Dumble, M., Moore, L., Chambers, S. M., Geiger, H., Van Zant, G., Goodell, M. A., & Donehower, L. A. (2007) · Blood · doi:10.1182/blood-2006-03-010413 · Cited by 241
Relevance of the p53–MDM2 axis to aging
Wu, D., & Prives, C. (2018) · Cell Death & Differentiation · doi:10.1038/cdd.2017.187 · Cited by 215
Translational Repression of C. elegans p53 by GLD-1 Regulates DNA Damage-Induced Apoptosis
Schumacher, B., Hanazawa, M., Lee, M.-H., Nayak, S., Volkmann, K., Hofmann, R., Hengartner, M., Schedl, T., & Gartner, A. (2005) · Cell · doi:10.1016/j.cell.2004.12.009 · Cited by 214
Self-citationTargeted point mutations of p53 lead to dominant-negative inhibition of wild-type p53 function
de Vries, A., Flores, E. R., Miranda, B., Hsieh, H.-M., van Oostrom, C. T. M., Sage, J., & Jacks, T. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052713099 · Cited by 207
Haas, L., Elewaut, A., Gerard, C. L., Umkehrer, C., Leiendecker, L., Pedersen, M., Krecioch, I., Hoffmann, D., Novatchkova, M., Kuttke, M., et al. (2021) · Nature Cancer · doi:10.1038/s43018-021-00221-9 · Cited by 196
A single gene and a pseudogene for the cellular tumour antigen p53
Zakut-Houri, R., Oren, M., Bienz, B., Lavie, V., Hazum, S., & Givol, D. (1983) · Nature · doi:10.1038/306594a0 · Cited by 192
HIF-1 antagonizes p53-mediated apoptosis through a secreted neuronal tyrosinase
Sendoel, A., Kohler, I., Fellmann, C., Lowe, S. W., & Hengartner, M. O. (2010) · Nature · doi:10.1038/nature09141 · Cited by 192
C. elegans ced-13 can promote apoptosis and is induced in response to DNA damage
Schumacher, B., Schertel, C., Wittenburg, N., Tuck, S., Mitani, S., Gartner, A., Conradt, B., & Shaham, S. (2005) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401539 · Cited by 186
Self-citationTemporal dissection of p53 function in vitro and in vivo
Christophorou, M. A., Martin-Zanca, D., Soucek, L., Lawlor, E. R., Brown-Swigart, L., Verschuren, E. W., & Evan, G. I. (2005) · Nature Genetics · doi:10.1038/ng1572 · Cited by 184
p53 Linear Diffusion along DNA Requires Its C Terminus
McKinney, K., Mattia, M., Gottifredi, V., & Prives, C. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.09.032 · Cited by 174
Cancer-Specific Loss of p53 Leads to a Modulation of Myeloid and T Cell Responses
Blagih, J., Zani, F., Chakravarty, P., Hennequart, M., Pilley, S., Hobor, S., Hock, A. K., Walton, J. B., Morton, J. P., Gronroos, E., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2019.12.028 · Cited by 173
Bispecific antibodies targeting mutant RAS neoantigens
Douglass, J., Hsiue, E. H.-C., Mog, B. J., Hwang, M. S., DiNapoli, S. R., Pearlman, A. H., Miller, M. S., Wright, K. M., Azurmendi, P. A., Wang, Q., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abd5515 · Cited by 171
Tumour suppression by p53: the importance of apoptosis and cellular senescence
Zuckerman, V., Wolyniec, K., Sionov, R. V., Haupt, S., & Haupt, Y. (2009) · The Journal of Pathology · doi:10.1002/path.2584 · Cited by 170
The cellular oncogene p53 can be activated by mutagenesis
Jenkins, J. R., Rudge, K., Chumakov, P., & Currie, G. A. (1985) · Nature · doi:10.1038/317816a0 · Cited by 169
Guo, G., Yu, M., Xiao, W., Celis, E., & Cui, Y. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2832 · Cited by 168
Gambino, V., de Michele, G., Venezia, O., Migliaccio, P., Dall’Olio, V., Bernard, L., Minardi, S. P., Fazia, M. A. D., Bartoli, D., Servillo, G., et al. (2013) · Aging Cell · doi:10.1111/acel.12060 · Cited by 165
Cao, L., Kim, S., Xiao, C., Wang, R., Coumoul, X., Wang, X., Li, W. M., Xu, X. L., Soto, J. A. D., Takai, H., et al. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601115 · Cited by 164
Gain-of-Function Mutant p53: All the Roads Lead to Tumorigenesis
Stein, Y., Rotter, V., & Aloni-Grinstein, R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20246197 · Cited by 162
Lo, W., Parkhurst, M., Robbins, P. F., Tran, E., Lu, Y.-C., Jia, L., Gartner, J. J., Pasetto, A., Deniger, D., Malekzadeh, P., et al. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0686 · Cited by 158
Increased gene dosage of Ink4a/Arf results in cancer resistance and normal aging
Matheu, A., Pantoja, C., Efeyan, A., Criado, L. M., Martín‐Caballero, J., Flores, J. M., Klatt, P., & Serrano, M. (2004) · Genes & Development · doi:10.1101/gad.310304 · Cited by 156
Transcriptional Regulation by Wild-Type and Cancer-Related Mutant Forms of p53
Pfister, N. T., & Prives, C. L. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026054 · Cited by 156
Liu, L., Charville, G. W., Cheung, T. H., Yoo, B., Santos, P. J., Schroeder, M., & Rando, T. A. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.08.019 · Cited by 156
Fang, D. D., Tang, Q., Kong, Y., Wang, Q., Gu, J., Fang, X., Zou, P., Rong, T., Wang, J., Yang, D., et al. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0750-6 · Cited by 151
The RAS signal transduction pathway and its role in radiation sensitivity
McKenna, W. G., Muschel, R. J., Gupta, A., Hahn, S. M., & Bernhard, E. J. (2003) · Oncogene · doi:10.1038/sj.onc.1206699 · Cited by 149
Mutant p53 proteins counteract autophagic mechanism sensitizing cancer cells to mTOR inhibition
Cordani, M., Oppici, E., Dando, I., Butturini, E., Dalla Pozza, E., Nadal-Serrano, M., Oliver, J., Roca, P., Mariotto, S., Cellini, B., et al. (2016) · Molecular Oncology · doi:10.1016/j.molonc.2016.04.001 · Cited by 141
Mutant p53s generate pro-invasive niches by influencing exosome podocalyxin levels
Novo, D., Heath, N., Mitchell, L. E., Caligiuri, G., MacFarlane, A., Reijmer, D., Charlton, L., Knight, J. R. P., Calka, M., McGhee, E. J., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07339-y · Cited by 134
Puma is required for p53-induced depletion of adult stem cells
Liu, D., Ou, L. Y., Clemenson, G. D., Chao, C., Lutske, M. E., Zambetti, G. P., Gage, F. H., & Xu, Y. (2010) · Nature Cell Biology · doi:10.1038/ncb2100 · Cited by 123
Arandkar, S., Furth, N., Elisha, Y., Nataraj, N. B., van der Kuip, H., Yarden, Y., Aulitzky, W. E., Ulitsky, I., Geiger, B., & Oren, M. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1719076115 · Cited by 118
Antigen Experienced T Cells from Peripheral Blood Recognize p53 Neoantigens
Malekzadeh, P., Yossef, R., Cafri, G., Paria, B. C., Lowery, F. J., Jafferji, M. S., Good, M. L., Sachs, A., Copeland, A. R., Kim, S. P., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-1874 · Cited by 117
LH prevents cisplatin-induced apoptosis in oocytes and preserves female fertility in mouse
Rossi, V., Lispi, M., Longobardi, S., Mattei, M., Rella, F. D., Salustri, A., Felici, M. D., & Klinger, F. G. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2016.97 · Cited by 113
Kore, R. A., Edmondson, J. L., Jenkins, S. V., Jamshidi‐Parsian, A., Dings, R. P. M., Reyna, N. S., & Griffin, R. J. (2018) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2018.03.008 · Cited by 102
Regulation of Cell Death and Immunity by XIAPPreprint
Jost, P. J., & Vucic, D. (2019) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a036426 · Cited by 100
Rovinski, B., Munroe, D. G., Peacock, J. W., Mowat, M. R. A., Bernstein, A., & Benchimol, S. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.2.847 · Cited by 96
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
THIERS, B. H. (2008) · Yearbook of Dermatology and Dermatologic Surgery · doi:10.1016/s0093-3619(08)70921-3 · Cited by 94
The common germline Arg72Pro polymorphism of p53 and increased longevity in humans
Bojesen, S. E., & Nordestgaard, B. G. (2008) · Cell Cycle · doi:10.4161/cc.7.2.5249 · Cited by 93
Trbušek, M., Šmardová, J., Malčíková, J., Šebejová, L., Dobes, P., Svitáková, M., Vranová, V., Mráz, M., Francová, H. S., Doubek, M., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.34.7872 · Cited by 93
Mutant p53 induces Golgi tubulo-vesiculation driving a prometastatic secretome
Capaci, V., Bascetta, L., Fantuz, M., Beznoussenko, G. V., Sommaggio, R., Cancila, V., Bisso, A., Campaner, E., Aa, M., Wiśniewski, J. R., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17596-5 · Cited by 91
Gannon, H. S., Donehower, L. A., Lyle, S., & Jones, S. N. (2011) · Developmental Biology · doi:10.1016/j.ydbio.2011.02.007 · Cited by 87
Structural basis for oligoclonal T cell recognition of a shared p53 cancer neoantigen
Wu, D., Gallagher, D. T., Gowthaman, R., Pierce, B. G., & Mariuzza, R. A. (2020) · Nature Communications · doi:10.1038/s41467-020-16755-y · Cited by 78
Control of Cellular Aging, Tissue Function, and Cancer by p53 Downstream of Telomeres
Roake, C. M., & Artandi, S. E. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026088 · Cited by 75
p53 isoforms regulate premature aging in human cells
von Muhlinen, N., Horikawa, I., Alam, F., Isogaya, K., Lissa, D., Vojtesek, B., Lane, D. P., & Harris, C. C. (2018) · Oncogene · doi:10.1038/s41388-017-0101-3 · Cited by 74
Hypoxia and IF1 Expression Promote ROS Decrease in Cancer Cells
Sgarbi, G., Gorini, G., Liuzzi, F., Solaini, G., & Baracca, A. (2018) · Cells · doi:10.3390/cells7070064 · Cited by 65
The tumour suppressor CYLD regulates the p53 DNA damage response
Fernández‐Majada, V., Welz, P.-S., Ermolaeva, M., Schell, M. J., Adam, A. C., Dietlein, F., Komander, D., Büttner, R., Thomas, R. K., Schumacher, B., et al. (2016) · Nature Communications · doi:10.1038/ncomms12508 · Cited by 64
Self-citationDNA damage responses in ageing
da Silva, P. F. L., & Schumacher, B. (2019) · Open Biology · doi:10.1098/rsob.190168 · Cited by 63
Self-citationA polymorphism in the tumor suppressor p53 affects aging and longevity in mouse models
Zhao, Y., Wu, L., Yue, X., Zhang, C., Wang, J., Li, J., Sun, X., Zhu, Y., Feng, Z., & Hu, W. (2018) · eLife · doi:10.7554/elife.34701 · Cited by 57
The SCFFSN-1 ubiquitin ligase controls germline apoptosis through CEP-1/p53 in C. elegans
Gao, M. X., Liao, E. H., Yu, B., Wang, Y., Zhen, M., & Derry, W. B. (2008) · Cell Death and Differentiation · doi:10.1038/cdd.2008.30 · Cited by 56
The N Terminus of p53 Regulates Its Dissociation from DNA
Cain, C. R., Miller, S., Ahn, J., & Prives, C. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002509200 · Cited by 53
Restoration of p53 function leads to tumour regression in vivo
THIERS, B. H. (2008) · Yearbook of Dermatology and Dermatologic Surgery · doi:10.1016/s0093-3619(08)70920-1 · Cited by 50
Yang, H., Sun, L., Guan, A., Yin, H., Liu, M., Mao, X., Xu, H. C., Zhao, H., Lü, X., Sang, X., et al. (2020) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-020-02711-8 · Cited by 50
CCR5 and p53 codon 72 gene polymorphisms: Implications in breast cancer development
Watanabe (2009) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000148 · Cited by 49
Hauck, L., Stanley-Hasnain, S., Fung, A., Grothe, D., Rao, V., Mak, T. W., & Billia, F. (2017) · PLoS ONE · doi:10.1371/journal.pone.0189861 · Cited by 48
Moyer, S. M., Wasylishen, A. R., Qi, Y., Fowlkes, N. W., Su, X., & Lozano, G. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2008474117 · Cited by 48
Mutant p53 Attenuates the Anti-Tumorigenic Activity of Fibroblasts-Secreted Interferon Beta
Madar, S., Harel, E., Goldstein, I., Stein, Y., Kogan-Sakin, I., Kamer, I., Solomon, H., Dekel, E., Tal, P., Goldfinger, N., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061353 · Cited by 44
Vater, C. A., Bartle, L. M., Dionne, C. A., Littlewood, T. D., & Goldmacher, V. S. (1996) · PubMed · Cited by 42
Moore, L. M., Lu, X., Ghebranious, N., Tyner, S. D., & Donehower, L. A. (2007) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2007.10.011 · Cited by 40
Song, Z., Zhang, J., Ju, Z., & Rudolph, K. L. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2012.00802.x · Cited by 37
Habermehl, T. L., Parkinson, K. C., Hubbard, G. B., Ikeno, Y., Engelmeyer, J. I., Schumacher, B., & Mason, J. B. (2018) · GeroScience · doi:10.1007/s11357-018-0049-4 · Cited by 37
Self-citationSomatic Niche Cells Regulate the CEP-1/p53-Mediated DNA Damage Response in Primordial Germ Cells
Ou, H., Kim, C. S. K., Uszkoreit, S., Wickström, S. A., & Schumacher, B. (2019) · Developmental Cell · doi:10.1016/j.devcel.2019.06.012 · Cited by 36
Self-citationPhosphorylation Control of p53 DNA-Binding Cooperativity Balances Tumorigenesis and Aging
Timofeev, O. N., Koch, L., Niederau, C., Tscherne, A., Schneikert, J., Klimovich, M., Elmshäuser, S., Zeitlinger, M. A., Mernberger, M., Nist, A., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-2002 · Cited by 34
A small-molecule ARTS mimetic promotes apoptosis through degradation of both XIAP and Bcl-2
Mamriev, D., Abbas, R., Klingler, F., Kagan, J., Kfir, N., Donald, A., Weidenfeld, K., Sheppard, D. W., Barkan, D., & Larisch, S. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2670-2 · Cited by 33
P53 Mutant p53N236S Regulates Cancer-Associated Fibroblasts Properties Through Stat3 Pathway
Liu, Q., Yu, B., Tian, Y., Dan, J., Luo, Y., & Wu, X. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s229065 · Cited by 31
The Cdkn1aSUPER Mouse as a Tool to Study p53-Mediated Tumor Suppression
Torgovnick, A., Heger, J., Liaki, V., Isensee, J., Schmitt, A., Knittel, G., Riabinska, A., Beleggia, F., Laurien, L., Leeser, U., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.09.079 · Cited by 29
Self-citationJiang, L., Malik, N., Acedo, P., & Zawacka‐Pankau, J. (2019) · Cell Death Discovery · doi:10.1038/s41420-019-0157-7 · Cited by 29
Novel p53 target genes secreted by the liver are involved in non-cell-autonomous regulation
Charni, M., Molchadsky, A., Goldstein, I., Solomon, H., Tal, P., Goldfinger, N., Yang, P., Porat, Z., Lozano, G., & Rotter, V. (2015) · Cell Death and Differentiation · doi:10.1038/cdd.2015.119 · Cited by 22
p53 dynamics in single cells are temperature-sensitive
Jentsch, M., Snyder, P., Sheng, C., Cristiano, E., & Loewer, A. (2020) · Scientific Reports · doi:10.1038/s41598-020-58267-1 · Cited by 20
Dong, Y.-L., Vadla, G. P., Lu, J., Ahmad, V., Klein, T. J., Liu, L., Glazer, P. M., Xu, T., & Chabu, C. Y. (2021) · Communications Biology · doi:10.1038/s42003-021-01898-5 · Cited by 20
Various stress stimuli rewire the profile of liver secretome in a p53-dependent manner
Charni‐Natan, M., Solomon, H., Molchadsky, A., Jacob-Berger, A., Goldfinger, N., & Rotter, V. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0697-4 · Cited by 12
A bidirectional crosstalk between autophagy and TP53 determines the pace of aging
Sica, V., & Kroemer, G. (2020) · Molecular & Cellular Oncology · doi:10.1080/23723556.2020.1769434 · Cited by 4
Fan, H., Yu, I., Lin, Y., Wang, S., Liaw, Y., Chen, P., Yang, T., Lin, S., & Chen, Y. (2019) · The FASEB Journal · doi:10.1096/fj.201802027r · Cited by 2
Research works printed but not linked: 5
- Jay, 1980, A common transformation-related protein in murine sarcomas and leukemias, Cold Spring Harb. Symp. Quant. Biol., 44, 659, 10.1101/SQB.1980.044.01.069 · doi:10.1101/sqb.1980.044.01.069
- Zhu, 2020, The establishment of esophageal precancerous lesion model by using p53 conditional knockout mouse in esophageal epithelium, Biomed. Res. Int., 2020, 4534289, 10.1155/2020/4534289 · DOI
- Bojesen, 2008, 7(2), 158
- von Muhlinen, 2018, p53 isoforms regulate premature aging in human cells, Oncogene 2018 37:18, 37, 2379
- Ackermann, 2016, E4 ligase–specific ubiquitination hubs coordinate DNA double-strand-break repair and apoptosis, Nat. Struct. Mol. Biol., 23, 995, 10.1038/nsmb.3296 · DOI
Cited by
Targeting p53 pathways: mechanisms, structures, and advances in therapy
Wang, H., Guo, M., Wei, H., & Chen, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01347-1 · Cited by 1,016
Mutant p53 in cancer: from molecular mechanism to therapeutic modulation
Chen, X., Zhang, T., Su, W., Dou, Z., Zhao, D., Jin, X., Lei, H., Wang, J., Xie, X., Cheng, B., et al. (2022) · Cell Death & Disease · doi:10.1038/s41419-022-05408-1 · Cited by 494
Focus on the Contribution of Oxidative Stress in Skin Aging
Papaccio, F., D′Arino, A., Caputo, S., & Bellei, B. (2022) · Antioxidants · doi:10.3390/antiox11061121 · Cited by 396
Pu.1/Spi1 dosage controls the turnover and maintenance of microglia in zebrafish and mammals
Wu, Y., Guo, W., Kuang, H., Wu, X., Trinh, T. H., Wang, Y., Zhao, S., Wen, Z., & Yu, T. (2025) · eLife · doi:10.7554/elife.105788 · Cited by 9
Pu.1/Spi1 dosage controls the turnover and maintenance of microglia in zebrafish and mammals
Wu, Y., Guo, W., Kuang, H., Wu, X., Trinh, T. H., Wang, Y., Zhao, S., Wen, Z., & Yu, T. (2023) · bioRxiv (Preprint) · doi:10.1101/2023.12.14.570333 · Cited by 1
“…recent studies have revealed that, in addition to regulating cell cycle arrest and apoptosis in DNA damage response (Ou & Schumacher, 2018, Vaddavalli & Schumacher, 2022), Tp53 is also involved in cell competition regulation in both hematopoietic and non-hemopoietic tissues (Bondar &…”
Metadata
- Authors
- Vaddavalli, P. L., & Schumacher, B.
- Venue
- Trends in Genetics
- Publisher
- Elsevier BV
- Published
- 2022-06
- Volume
- 38
- Issue
- 6
- Pages
- 598-612
- ISSN
- 0168-9525 (ISSN-L)
- OpenAlex
- W4221041309
- Cited by
- 279
- References
- 114
- FWCI
- 9.85
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Funders
- Deutsche Forschungsgemeinschaft (KFO 286, KFO 329, SFB 829, GRK 2407, SFB 670, SCHU 2494/3-1, SCHU 2494/15-1, SCHU 2494/10-1, SCHU 2494/11-1, SCHU 2494/7-1)
- Horizon 2020
- Stiftung Deutsche Krebshilfe (70112899)
- John Templeton Foundation (61734)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.